Skip to content

The value of interval faecal occult blood testing in colonoscopic screening programs for those at above average risk for colorectal cancer.

The value of interval faecal occult blood testing in colonoscopic screening programs for those at above average risk for colorectal cancer.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12607000459426
Enrollment
1000
Registered
2007-09-11
Start date
2001-12-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study examines the value of interval faecal occult blood test within a colonoscopy-based surveillance program for those at moderately increased risk for developing colorectal cancer. Who is it for? You may be eligible for this study if you are considered to be at moderate risk for colorectal cancer development based on a personal history of colonic adenomas or colorectal cancer or have a verified family history. You also need to be currently registered with one of the Southern Adelaide regional public hospital colorectal cancer prevention programs. Trial details. A faecal occult blood test is a test that can detect tiny traces of blood in the stool which cannot be seen with the naked eye. ‘Occult’ literally means hidden or unknown. A positive faecal occult blood test should be followed by a colonoscopy where colorectal cancer or significant large polyps may be diagnosed at a relatively early stage when there are no obvious symptoms. At present, participants registered with the colonoscopy surveillance program in Southern Adelaide region have scheduled colonoscopies in accordance with the National Health and Medical Research Council’s clinical practice guidelines (2005), at a frequency depending on risk level. Eligible registrants will be offered a faecal occult blood test (interval test) in each of the years between scheduled colonoscopies. The study compares the yield of colorectal cancers and adenomas detected at colonoscopies between participants who do have interval faecal occult blood tests and those who choose not to participate.

Interventions

Ongoing annual offer of faecal occult blood test screening in years when colonoscopy not scheduled, within a colonoscopy based surveillance program. At present the duration would be ongoing till the invitee reaches 75 years, then subject to invitee's wishes and health status.

Sponsors

Flinders University
Lead SponsorUniversity

Study design

Allocation
Non-randomised trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

Registered on colonoscopy surveillance database, having undergone at least 2 adequate colonoscopies greater than 1 year apart,

Exclusion criteria

Full pathology details not available for lesions detected.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026